Registering radiation given during breast-conserving surgery
Part of Cancer, Skin clinical trials.
This study records details about radiation delivered while your surgery is happening for certain early breast cancers or pre-cancers. It may help doctors better understand who benefits most from this “intra-operative” radiation approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and age 45 or older
- You have early-stage estrogen-receptor–positive breast cancer (or DCIS) that fits a specific size/stage range
- Your cancer is expected to be treated with breast-conserving surgery (lumpectomy)
- You must have planned to receive intra-operative radiation during surgery and be safe to have radiation
- You have had a mammogram within the last 6 months before the planned procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about people with early-stage, hormone-receptor–positive breast cancer who have a lumpectomy and radiation. It may help doctors understand outcomes after this standard treatment and improve care for future patients.
This trial is for women aged 55 or older with very early-stage breast cancer (stage 0 or 1) who want to save their breast. It tests giving a single dose of radiation during the lumpectomy instead of weeks of daily radiation afterward.
This study uses a special test (DCISionRT) on tissue from your breast surgery to help doctors decide if radiation therapy is right for you after lumpectomy for DCIS (a non-invasive form of breast cancer). The goal is to personalize treatment based on your individual cancer characteristics.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
This study gives radiation to the breast before surgery to see if some people can safely delay or even skip surgery. It targets women with a small, node-negative, ER-positive breast cancer with low genetic risk.
This trial tests giving radiation to the tumor area before surgery for women with early-stage, hormone-sensitive breast cancer. The idea is to see if giving radiation first can help protect healthy tissue while still being effective.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.